Emergency Department MCG for Suspected Acute Coronary Syndrome

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02699788

Enrollment

Registered

2016-03-04

Start date

2016-04-30

Completion date

2017-11-29

Last updated

2019-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Brief summary

The goal of this study is to assess a new non-invasive computerized, multiphase, resting electrocardiogram analysis device in early identification of patients at risk for acute coronary syndrome. The overall objective is to assess the association between the results from a resting MCG and 30-day cardiovascular outcome in patients presenting to the emergency department with suspected coronary disease.

Interventions

DEVICEMultifunction Cardiogram

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 18 and over. * Symptoms consistent with a possible acute coronary syndrome per the treating emergency physician. * Has an electrocardiogram performed while in the ED.

Exclusion criteria

* Acute ST-segment elevation MI. * Patient unable or unwilling to complete follow-up.

Design outcomes

Primary

Measure	Time frame	Description
Accuracy of MCG as assessed by the development of major adverse cardiac events (MACE).	30 days	MACE will be defined as the composite of cardiac death, myocardial infarction (MI), or coronary revascularization. 2.2 Seco11dary

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026